12 Jun 2017 10:39
RNS announcement | 12 June 2017 |
Bioquell PLC
("Bioquell", or "the Company")
Purchase of own shares
Further to the Company's announcement on 3 May 2017 stating its intention to reduce its capital by means of purchasing its shares from time to time using existing cash resources, the Company announces that on 9 June 2017 it purchased 25,000 of its ordinary shares on the London Stock Exchange at a price of 165 pence per share. The purchased shares will all be held as treasury shares.
Aggregated information:
Date of purchase: | 9 June 2017 |
Number of ordinary shares purchased: | 25,000 |
Volume weighted average price paid per share: | 165 pence |
Transaction details: | |
Issuer name: | Bioquell Plc |
ISIN: | GB0004992003 |
Timezone: | GMT |
Currency: | GBP |
Total Number of Voting Rights
In accordance with DTR 5.6.1 of the FCA's Disclosure Guidance and Transparency Rules, the Company is required to notify the market of the total number of voting rights and capital in the Company as at the end of each calendar month in which an increase or decrease has occurred.
The issued share capital of the Company is comprised of 23,188,917 ordinary shares of 10p each. As 727,000 of these ordinary shares are held as treasury shares, the total number of voting rights in the Company is 22,461,917. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries:
Bioquell PLC | Tel: +44 (0)1264 835800 | |
Ian Johnson, Executive Chairman | ||
Michael Roller, Finance Director | ||
N+1 Singer | Tel: +44 (0) 20 7496 3000 | |
Mark Taylor